A new treatment trial is giving patients their radiation during a breast-conserving lumpectomy procedure, and not after. A breakthrough for early-stage breast cancer patients with invasive ductal carcinoma,...
-
Recent Posts
Join Our Mailing List
A new treatment trial is giving patients their radiation during a breast-conserving lumpectomy procedure, and not after. A breakthrough for early-stage breast cancer patients with invasive ductal carcinoma,...
While its widespread use as a standard treatment is still a decade or more away, physicians at Johns Hopkins Cancer Center report they now can successfully inject cancer-fighting drugs straight into a breast...
Researchers have found that mice fed special diets containing 5-10% blueberry powder experienced significantly reduced growth and spread of their aggressive triple negative breast cancer cells. Multiple...
About half of women with lobular breast cancer may be able to save their affected breast by undergoing chemotherapy prior to breast surgery, an Austrian study has found. Historically, chemotherapy was thought...
Fearing complications for both mother and child, chemotherapy for years was not an option for pregnant women with breast cancer. However, contrary to widely-held beliefs, new data from researchers at The University...
A two-part series on the continuing evolution of support groups. Like a fingerprint, each breast cancer diagnosis is unique. From the tumor’s type and progression to its treatment strategy and eventual...
A “game-changing” study by the Swiss drug maker Novartis has shown that its kidney-cancer drug Afinitor also works to slow breast cancer’s progression. The study followed women with breast cancer...
The Mayo Clinic in Rochester, Minnesota, has developed a promising new vaccine intended to help stave off breast and ovarian cancer in women. The vaccine, still years away from widespread use, is thought...
A newly-developed protein called Affitoxin has been shown in lab tests to effectively destroy HER2-positive breast tumors that have stopped responding to Herceptin. Women with HER2-positive breast cancer...
The aggressive chemotherapy treatments many women endure as a breast cancer therapy have a host of unpleasant side effects. One that is especially significant to the 12 percent of patients under age 45 is the risk...